Medtech acceleration
We are serial entrepreneurs using a unique model to discover and nurture ground-breaking ideas for therapeutic medical devices.
We create and build companies to turn the best of these ideas into tools that practitioners can use to save and improve patients’ lives.
Close | Fund | AMT |
---|---|---|
2008 | MD Start I | €8.2 million |
2015 | MD Start II | €10.3 million |
2019 | Sofinnova MD Start III | €63 million |
Close: 2008
Fund: MD Start I
AMT: €8.2 million
Close: 2015
Fund: MD Start II
AMT: €10.3 million
Close: 2019
Fund: Sofinnova MD Start III
AMT: €63 million
“We’re not trying to find ways to use new technologies in medicine. We start from the clinical need. From there, we try to find technologies that will help us develop products that are going to solve that need.”
“Sofinnova has realized something truly impressive in developing a first-class medtech ecosystem based out of Europe.”
"Sofinnova truly embodies the pioneering spirit of innovation in the life sciences."
The
Team
Anne Osdoit
Partner, Sofinnova Partners - MD Start Strategy
Cécile Dupont
Partner, Sofinnova Partners - MD Start Strategy
Marion Gasperment
Associate, Program Manager, Sofinnova Partners - MD Start Strategy
Mano Iyer
Partner, Sofinnova Partners - MD Start Strategy
Gérard Hascoët
Venture Partner, Sofinnova Partners - MD Start Strategy
Companies
MD Start
Advanced Perfusion Diagnostics
MD Start
BrightHeart
Capital & MD Start
CorWave
MD Start
Endoron Medical
MD Start
Gradient Denervation Technologies
MD Start
HEPTA Medical
MD Start
Julier Medical
MD Start & Crossover
LimFlow
Capital & MD Start
May Health
Capital & MD Start
Moon Surgical
MD Start
preCARDIA
Capital & MD Start
SafeHeal
0 results
Related News
Enhanced data security and quality via ISO 27001:2022 and SOC 2 certifications enables Moon Surgical to deliver actionable insights to healthcare providers
Gradient Denervation Technologies appoints Stanton Rowe to Board of Directors and receives FDA approval to expand early feasibility study
HEPTA Medical secures €5.7 million Series A, led by BPI France to advance minimally invasive lung cancer treatment
Video: Sofinnova Partners 2024 annual general meeting
Endoron Medical raises $10 Million in Series A funding led by Sofinnova Partners to accelerate the validation of its AAA EndoStapling solution Aortoseal